Bahrain medical device registration timeline
Source-linked clocksNational Health Regulatory Authority (NHRA) review clocks and end-to-end planning ranges, using the 4-class device axis (I, IIa, IIb, III) and separate 4-class IVD axis (A, B, C, D) — NHRA Medical Device Classification Guideline Ver 2.4 classification system.
4 pathways4 of 4 clocks verifiedvalidity Three years: Article (10) of Resolution No. (48) of 2020, as replaced by Resolution No. (69) of 2024, provides that the marketing authorization for devices meeting global quality and safety standards is valid for three years after full payment of the prescribed fees, and Circular No. (15) of 2026 confirms that all medical device registrations have a 3-year validity period. Registration Guideline Version 9.1 still prints a one-year validity — see unresolved.registrationValidity.MDSAP not acceptedreviewed 2026-09-16nhra.bh
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Medical device registration — standard NHRA review(Application filed by a registered Bahrain Authorized Representative: the device is listed with NHRA, an appointment is booked in the Ajheza system, and the full dossier is submitted at the appointment) Registration Guideline Version 9.1, general rule 11: 'The timeframe of registration application review is 20 working days.' Section 3 repeats it: 'The review process timeframe is 20 working days.' | 20 working days | 1-3 months | — | Verified |
| Medical device registration — fast track through third-party services(Registration application routed through a third-party service provider) Registration Guideline Version 9.1, general rule 11: 'Fast track (Through third party services) is also available with a time frame of 10 working days.' | 10 working days | 1-2 months | — | Verified |
| Product classification request — NHRA classification letter(Application for a classification letter, submitted with the free sale certificate or registration certificate from the country of origin or a reference country and a recognised quality assurance certificate) Classification Guideline Version 2.4, section 2: 'Timeline for reviewing the submitted documents after fees payment is 1 to 2 weeks.' | 1-2 weeks | 2-6 weeks | — | Verified |
| Minor variation review(Variation application on the NHRA variation form, filed when the change does not affect the safety or performance of the device) Registration Guideline Version 9.1, section 9 general directions: 'Timeframe of NHRA review is 20 working days.' | 20 working days | 1-2 months | — | Verified |
Review clocks exclude applicant hold time · planning totals are estimatesPlanning steps and estimates; these are not regulator deadlines.
Bahrain Medical Device Registration Process
Step-by-step NHRA registration process. Total estimated timeline: 1-3 months.
Step 1: Pre-Submission Preparation
1-3 monthsGather technical documentation, quality management system (QMS) records, and clinical data required by NHRA. Appoint a Bahrain Authorized Representative (AR) — a facility licensed by NHRA.
Step 2: Application Submission
1-2 weeksSubmit complete registration dossier to NHRA including device description, risk analysis, and testing reports.
Step 3: Administrative Review
2-4 weeksNHRA reviews application for completeness. May request additional documents or clarifications.
Step 4: Technical Evaluation
20 working daysIn-depth technical assessment of device safety and performance. NHRA may issue questions.
Step 5: Registration Approval
1-2 weeksUpon successful review, NHRA issues Bahrain market authorization certificate.
Summary: The Bahrain medical device registration process through National Health Regulatory Authority (NHRA) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
Registration certificate from SFDA (Saudi Arabia), US FDA, TGA (Australia), PMDA (Japan), MHRA (United Kingdom), HPRA (Ireland), Swissmedic (Switzerland), ANSM (France) or BfArM (Germany)Article (7) bis of Resolution No. (48) of 2020, inserted by Resolution No. (69) of 2024, provides by way of exception to the ordinary Article (7) prohibition that medical devices and products registered in one of the nine listed reference countries 'shall also be registered in the Kingdom of Bahrain' on the basis of that country's registration certificate, on payment of the applicable fee. This is a documentary registration route rather than a full de novo technical assessment, but the application is still filed by a licensed Bahraini Authorized Representative and NHRA retains the decision.
EU CE certificate under MDD 93/42/EEC, MDR 2017/745, IVDD 98/79/EC or IVDR 2017/746, or US FDA Certificate to Foreign GovernmentMandatory supporting documentation for a local review that still runs in full, not a route that shortens it: the CE certificate or CFG is the Quality Assurance Certificate required for the legal manufacturer, and for class III and class D IVDs the EC Design Examination certificate or CFG is an additional class-specific dossier item.
GCC central registration issued by the Gulf Health Council, or GSO/G-mark conformityThere is no GCC device mutual recognition reaching Bahrain. Resolution No. (85) of 2023 simply adopts the Gulf standard specifications for the health sector issued by the GCC Standardization Organization as Bahraini national standards, which is standard harmonisation; the only way another GCC member's registration helps is through the Article (7) bis route, in which SFDA happens to be one of the nine named authorities.
Key requirements
- Only a facility licensed by NHRA as a Medical Device Authorized Representative may apply for, hold and renew a device registration; a manufacturer outside Bahrain cannot apply directly.
- Registration is mandatory for class IIa, IIb and III medical devices and for IVD classes B, C and D; registration of class I and IVD class A devices is optional.
- Every device intended for import must first be listed with NHRA on the medical devices listing sheet, which must not be submitted as part of the registration application.
- The dossier carries seven unconditional items including technical details (IFU, leaflet or user manual), artwork or label, the manufacturer's authorisation, and a Declaration of Conformity issued by the legal manufacturer; all official letters and documents must be signed and stamped by the issuer, with electronic signature and stamp accepted.
- Class III devices and class D IVDs must add an EC Design Examination certificate or an FDA Certificate to Foreign Government; class IIb devices must add one if available.
- The Quality Assurance Certificate is required for the legal manufacturer, must be verified on the issuing body's website and its address must match the artwork; a separate ISO 13485 certificate is required for the physical manufacturer.
- Accessories and spare parts cannot be registered separately; on importation the applicant must provide evidence from the legal manufacturer that the item is an accessory or spare part of a registered device.
- A registration application that does not meet all requirements is returned with two further submission attempts without repaying the application fee; a third failure is rejected and the fee must be paid again to resubmit.
- Appeals against a rejection must be submitted with justification within 10 working days.
- Imports require an OFOQ pre-approval filed with Customs Affairs before the shipment is dispatched, and the device must be imported in a form identical to the approved type.
- A device with a radio interface additionally requires a TRA type approval certificate before it may be supplied, imported or distributed, and CE-marked private-use equipment without radiocommunications interfaces is the only published exemption.
- Radiation-emitting devices additionally require an SCE approval to use ionizing radiation sources, applied for per model and serial number in the Environmental Licensing System.
Primary regulator sources
nhra.bh · NHRA Medical Devices Registration Guideline, Version 9.1 (September 2024) — general rules, process of submission, variation and renewal nhra.bh · NHRA Medical Device Classification Guideline, Version 2.4 (June 2022) — important rules, classification review time nhra.bh · NHRA Medical Device Registration SLA 2025 — service completion time
Reviewed 2026-09-16. End-to-end totals remain planning estimates.
Keep researching this market
More Bahrain medical device resources
Continue with this market
Source-linked review clocks verified against NHRA publications · full review 2026-09-16 · row IDs are stable — cite as registration-timeline:bahrain:registration-standard-review